MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts

Biochemical and Biophysical Research Communications

Volumn 350, Issue 2, 2006, Pages 377-384

  Toth, Marta ^a   Sohail, Anjum ^b   Mobashery, Shahriar ^a   Fridman, Rafael ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ectodomain shedding; Lipid rafts; Matrix metalloproteinases; Plasma membrane; Protease inhibitors; Tissue inhibitors of metalloproteinases

Indexed keywords

ADAM PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; MATRIX METALLOPROTEINASE 14; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE;

ADAM PROTEINS; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; MATRIX METALLOPROTEINASE 14; MEMBRANE MICRODOMAINS; PROTEASE INHIBITORS;

EID: 33749354580     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.052     Document Type: Article

References (44)

1. Bode W., Fernandez-Catalan C., Tschesche H., Grams F., Nagase H., and Maskos K. Structural properties of matrix metalloproteinases. Cell Mol. Life Sci. 55 (1999) 639-652
2. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 194 (2003) 1-11
3. Itoh Y., and Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell Physiol. 206 (2006) 1-8
4. Osenkowski P., Toth M., and Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J. Cell Physiol. 200 (2004) 2-10
5. Arribas J., and Merlos-Suarez A. Shedding of plasma membrane proteins. Curr. Top Dev. Biol. 54 (2003) 125-144
6. Toth M., Osenkowski P., Hesek D., Brown S., Meroueh S., Sakr W., Mobashery S., and Fridman R. Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase. Biochem. J. 387 (2005) 497-506
7. Imai K., Ohuchi E., Aoki T., Nomura H., Fujii Y., Sato H., Seiki M., and Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56 (1996) 2707-2710
8. Toth M., Hernandez-Barrantes S., Osenkowski P., Bernardo M.M., Gervasi D.C., Shimura Y., Meroueh O., Kotra L.P., Galvez B.G., Arroyo A.G., Mobashery S., and Fridman R. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J. Biol. Chem. 277 (2002) 26340-26350
9. Tam E.M., Morrison C.J., Wu Y.I., Stack M.S., and Overall C.M. Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 101 (2004) 6917-6922
10. Lehti K., Valtanen H., Wickstrom S., Lohi J., and Keski-Oja J. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J. Biol. Chem. 275 (2000) 15006-15013
11. Lauer-Fields J.L., Nagase H., and Fields G.B. Development of a solid-phase assay for analysis of matrix metalloproteinase activity. J. Biomol. Tech. 15 (2004) 305-316
12. Harayama T., Ohuchi E., Aoki T., Sato H., Seiki M., and Okada Y. Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line. Jpn. J. Cancer Res. 90 (1999) 942-950
13. Li H., Bauzon D.E., Xu X., Tschesche H., Cao J., and Sang Q.A. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol. Carcinog. 22 (1998) 84-94
14. Rozanov D.V., Deryugina E.I., Monosov E.Z., Marchenko N.D., and Strongin A.Y. Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. Exp. Cell Res. 293 (2004) 81-95
15. Fridman R., Fuerst T.R., Bird R.E., Hoyhtya M., Oelkuct M., Kraus S., Komarek D., Liotta L.A., Berman M.L., and Stetler-Stevenson W.G. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J. Biol. Chem. 267 (1992) 15398-15405
16. Fuerst T.R., Earl P.L., and Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell Biol. 7 (1987) 2538-2544
17. Hernandez-Barrantes S., Toth M., Bernardo M.M., Yurkova M., Gervasi D.C., Raz Y., Sang Q.A., and Fridman R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J. Biol. Chem. 275 (2000) 12080-12089
18. Olson M.W., Gervasi D.C., Mobashery S., and Fridman R. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272 (1997) 29975-29983
19. Galvez B.G., Matias-Roman S., Albar J.P., Sanchez-Madrid F., and Arroyo A.G. Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling. J. Biol. Chem. 276 (2001) 37491-37500
20. Brown S., Bernardo M.M., Zhi-Hong L., Kotra L.P., Tanaka Y., Fridman R., and Mobashery S. Potent and selective mechanism-based inhibition of gelatinases. J. Am. Chem. Soc. 122 (2000) 6780-6799
21. Kaup M., Dassler K., Weise C., and Fuchs H. Shedding of the transferrin receptor is mediated constitutively by an integral membrane metalloprotease sensitive to tumor necrosis factor alpha protease inhibitor-2. J. Biol. Chem. 277 (2002) 38494-38502
22. Pei D. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res. 9 (1999) 291-303
23. Solomon K.R., Mallory M.A., and Finberg R.W. Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells. Biochem. J. 334 Pt 2 (1998) 325-333
24. Williams T.M., and Lisanti M.P. The caveolin proteins. Genome Biol. 5 (2004) 214
25. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270 (1995) 5331-5338
26. Fridman R., Toth M., Pena D., and Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55 (1995) 2548-2555
27. Higashiyama S., and Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim. Biophys. Acta. 1751 (2005) 110-117
28. Lee H.J., Jung K.M., Huang Y.Z., Bennett L.B., Lee J.S., Mei L., and Kim T.W. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277 (2002) 6318-6323
29. Baker A.H., Edwards D.R., and Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115 (2002) 3719-3727
30. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
31. Turner A.J. Endothelin-converting enzymes and other families of metallo-endopeptidases. Biochem. Soc. Trans. 21 Pt 3 (1993) 697-701
32. Sumitomo M., Shen R., and Nanus D.M. Involvement of neutral endopeptidase in neoplastic progression. Biochim. Biophys. Acta. 1751 (2005) 52-59
33. Albright C.F., Graciani N., Han W., Yue E., Stein R., Lai Z., Diamond M., Dowling R., Grimminger L., Zhang S.Y., Behrens D., Musselman A., Bruckner R., Zhang M., Jiang X., Hu D., Higley A., Dimeo S., Rafalski M., Mandlekar S., Car B., Yeleswaram S., Stern A., Copeland R.A., Combs A., Seitz S.P., Trainor G.L., Taub R., Huang P., and Oliff A. Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity. Mol. Cancer Ther. 4 (2005) 751-760
34. Huovila A.P., Turner A.J., Pelto-Huikko M., Karkkainen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30 (2005) 413-422
35. Seals D.F., and Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17 (2003) 7-30
36. Zou J., Zhu F., Liu J., Wang W., Zhang R., Garlisi C.G., Liu Y.H., Wang S., Shah H., Wan Y., and Umland S.P. Catalytic activity of human ADAM33. J. Biol. Chem. 279 (2004) 9818-9830
37. Tanaka M., Nanba D., Mori S., Shiba F., Ishiguro H., Yoshino K., Matsuura N., and Higashiyama S. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands. J. Biol. Chem. 279 (2004) 41950-41959
38. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., Strongin A.Y., Brocker E.B., and Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell. Biol. 160 (2003) 267-277
39. Amour A., Knight C.G., Webster A., Slocombe P.M., Stephens P.E., Knauper V., Docherty A.J., and Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473 (2000) 275-279
40. Amour A., Knight C.G., English W.R., Webster A., Slocombe P.M., Knauper V., Docherty A.J., Becherer J.D., Blobel C.P., and Murphy G. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett. 524 (2002) 154-158
41. Annabi B., Lachambre M., Bousquet-Gagnon N., Page M., Gingras D., and Beliveau R. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem. J. 353 (2001) 547-553
42. Galvez B.G., Matias-Roman S., Yanez-Mo M., Vicente-Manzanares M., Sanchez-Madrid F., and Arroyo A.G. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol. Biol. Cell 15 (2004) 678-687
43. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
44. Zhuang L., Lin J., Lu M.L., Solomon K.R., and Freeman M.R. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res. 62 (2002) 2227-2231